AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,525 | +88.6% | 14,517 | +201.8% | 0.01% | +66.7% |
| Q2 2023 | $79,268 | +226380.0% | 4,810 | +24.8% | 0.00% | +200.0% |
| Q1 2023 | $35 | -22.2% | 3,854 | -38.3% | 0.00% | -50.0% |
| Q4 2022 | $45 | -99.9% | 6,250 | -56.5% | 0.00% | +100.0% |
| Q3 2022 | $72,000 | +620.0% | 14,364 | +236.6% | 0.00% | – |
| Q2 2022 | $10,000 | -65.5% | 4,267 | +1.8% | 0.00% | – |
| Q1 2022 | $29,000 | -81.8% | 4,191 | -78.8% | 0.00% | -100.0% |
| Q4 2021 | $159,000 | +165.0% | 19,770 | +225.1% | 0.00% | +50.0% |
| Q3 2021 | $60,000 | +3.4% | 6,082 | -28.4% | 0.00% | 0.0% |
| Q2 2021 | $58,000 | +114.8% | 8,497 | +186.4% | 0.00% | – |
| Q1 2021 | $27,000 | -73.5% | 2,967 | -80.5% | 0.00% | -100.0% |
| Q4 2020 | $102,000 | +85.5% | 15,246 | +39.4% | 0.00% | +200.0% |
| Q3 2020 | $55,000 | +1733.3% | 10,937 | +1329.7% | 0.00% | – |
| Q3 2019 | $3,000 | -62.5% | 765 | -70.7% | 0.00% | -100.0% |
| Q2 2019 | $8,000 | – | 2,614 | +1554.4% | 0.00% | – |
| Q1 2019 | $0 | – | 158 | -10.2% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 176 | -98.2% | 0.00% | -100.0% |
| Q1 2018 | $71,000 | +3450.0% | 9,740 | +5222.4% | 0.01% | – |
| Q4 2017 | $2,000 | -93.9% | 183 | -94.3% | 0.00% | -100.0% |
| Q3 2017 | $33,000 | -35.3% | 3,186 | -30.6% | 0.00% | -50.0% |
| Q2 2017 | $51,000 | +2450.0% | 4,593 | +1687.2% | 0.01% | – |
| Q1 2017 | $2,000 | – | 257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |